NAFLD is considered by many as the hepatic manifestation of the metabolic syndrome, currently conceptualized as a state of chronic low-grade inflammation. NASH is the progressive form of NAFLD and ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Identify the warning signs of hepatitis before they become serious. From subtle fatigue to more obvious symptoms, recognizing liver inflammation early can save.

Gilead's top late-stage drug selonsertib ... be announced later this year. NASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver, which ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

Novartis has added another non-alcoholic steatohepatitis (NASH) drug candidate to its pipeline ... The agreement focuses on PLN-1474, a preclinical-stage drug that works as a small-molecule ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Several studies have reported changes in hepatic histology from liver biopsies obtained at the time of bariatric surgery and after weight loss ( Table 1). Previous reviews [19,75–77] have ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...